We are live on ! Find out more
ACP

Acuta Capital Partners Portfolio holdings

AUM $142M
1-Year Est. Return 783.79%
This Fund
S&P 500
This Quarter Est. Return
+22.26%
1 Year Est. Return
+783.79%
3 Year Est. Return
+7,472.18%
5 Year Est. Return
+13,792.16%
10 Year Est. Return
+1,629,663.73%
AUM
$148M
AUM Growth
–
Cap. Flow
+$132M
Cap. Flow %
89.25%
Top 10 Hldgs %
53.27%
Holding
64
New
62
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
FOLD
Amicus Therapeutics
FOLD
+$11.2M
2
PTX
Pernix Therapeutics Holdings, Inc.
PTX
+$5.76M
3
ALIM
Alimera Sciences
ALIM
+$5.72M
4
BEAT
BioTelemetry, Inc.
BEAT
+$4.15M
5
LMAT icon
LeMaitre Vascular
LMAT
+$3.31M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 47.62%
2 Consumer Discretionary 1.43%
3 Financials 1.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FRSH
26
DELISTED
Papa Murphy's Holdings, Inc
FRSH
$1.63M 1.1%
+140,462
New +$1.38M
OCGN icon
27
Ocugen
OCGN
$424M
$1.5M 1.02%
+2,280
New +$1.5M
ASRT
28
DELISTED
Assertio
ASRT
$1.47M 0.99%
+1,516
New +$1.38M
HPTX
29
DELISTED
HYPERION THERAPEUTICS INC COM STK (DE)
HPTX
$1.45M 0.98%
+60,462
New +$1.36M
GWPH
30
CALL
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$1.35M 0.92%
+20,000
New +$1.46M
KIN
31
DELISTED
Kindred Biosciences, Inc.
KIN
$1.28M 0.87%
+171,807
New +$1.46M
FWP
32
DELISTED
Forward Pharma A/S American Depositary Shares
FWP
$1.26M 0.85%
+8,676
New +$1.25M
CERS icon
33
CALL
Cerus
CERS
$433M
$1.25M 0.84%
+200,000
New +$908K
AMAG
34
DELISTED
AMAG Pharmaceuticals
AMAG
$1.13M 0.77%
+26,596
New +$961K
PRTK
35
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$1.13M 0.76%
+29,252
New +$698K
CBMX
36
DELISTED
CombiMatrix Corporation
CBMX
$1.1M 0.74%
+56,885
New +$1.14M
ZINC
37
DELISTED
HORSEHEAD HLDG CORP COM STK (DE)
ZINC
$1.09M 0.73%
+68,577
New +$1.06M
AGEN
38
Agenus
AGEN
$326M
$1.07M 0.72%
+13,678
New +$842K
BLCM
39
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$1.05M 0.71%
+4,575
New +$981K
MOLG
40
DELISTED
MOL GLOBAL INC SPONSORED ADR
MOLG
$1.04M 0.7%
+339,575
New +$1.95M
CRDC
41
DELISTED
CARDICA INC COM NEW (DE)
CRDC
$1.03M 0.69%
+146,591
New +$1.21M
HRTX icon
42
Heron Therapeutics
HRTX
$96.8M
$1.02M 0.69%
+101,050
New +$825K
INNL
43
DELISTED
Innocoll Holdings plc Ordinary Shares
INNL
$974K 0.66%
+164,108
New +$1.14M
CEMP
44
PUT
DELISTED
Cempra, Inc.
CEMP
$940K 0.64%
+40,000
New +$598K
CASM
45
DELISTED
CAS Medical Systems, Inc.
CASM
$862K 0.58%
+522,467
New +$924K
GNVC
46
DELISTED
GenVec, Inc.
GNVC
$738K 0.5%
+35,478
New +$686K
ATHN
47
PUT
DELISTED
Athenahealth, Inc.
ATHN
$729K 0.49%
+5,000
New +$628K
NBIX icon
48
CALL
Neurocrine Biosciences
NBIX
$16.9B
$704K 0.48%
+31,500
New +$597K
ATRS
49
DELISTED
Antares Pharma, Inc.
ATRS
$598K 0.4%
+232,762
New +$523K
SQNM
50
DELISTED
SEQUENOM INC NEW
SQNM
$574K 0.39%
+155,135
New +$503K
1
2
3

Similar funds

EC
EJF Capital Arlington, Virginia $142M AUM 23.3% 1-Year Est. Return
YEPX
Yorktown Energy Partners XI New York $142M AUM 130.51% 1-Year Est. Return
SR
Summer Road West Palm Beach, Florida $142M AUM 43.61% 1-Year Est. Return
IA
IF Advisors San Antonio, Texas $141M AUM
MAM
Maytree Asset Management Hong Kong $141M AUM 114% 1-Year Est. Return
HA
HFG Advisors Cincinatti, Ohio $142M AUM 16.9% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
KCAM
Kagan Cocozza Asset Management Mickleton, New Jersey $142M AUM 12.02% 1-Year Est. Return

Acuta Capital Partners's Q4 2014 Portfolio in Review

Q4 2014 is the first quarter with a 13F filing on record for Acuta Capital Partners, which disclosed 64 positions worth $148M. Its ten largest holdings account for 53% of the portfolio.

Its largest position is Amicus Therapeutics: 1,632,720 shares worth $13.6M.

By sector, the portfolio is most concentrated in Healthcare at 48% of assets, followed by Consumer Discretionary and Financials.

  • Acuta Capital Partners's largest Q4 2014 buy was Amicus Therapeutics: 1,632,720 shares worth $13.6M.
  • Acuta Capital Partners's ten largest holdings make up 53% of its $148M portfolio in Q4 2014.
  • Acuta Capital Partners disclosed 64 positions in Q4 2014, its first 13F filing on record.

Based on Acuta Capital Partners's 13F filing for Q4 2014, filed 13 Feb 2015.